Sort
11,323 grants matching “glioblastoma”
IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)
$298,132Mark Linder · Pgxl Technologies, Llc · N43 · FY2015 · CA
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
$298,014Robert W Sobol · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · CA
Novel functions of Pyruvate kinase M2 in DNA double-strand break repair
$298,009Fen Xia · Univ Of Arkansas For Med Scis · R01 · FY2019 · CA
SAG E3 ubiquitin ligase in angiogenesis & carcinogenesis
$298,007Yi Sun · University Of Michigan At Ann Arbor · R01 · FY2010 · CA
SAG E3 ubiquitin ligase in angiogenesis & carcinogenesis
$298,007Yi Sun · University Of Michigan At Ann Arbor · R01 · FY2009 · CA
BIRN RESOURCES FACILITATE THE PERSONALIZATION OF MALIGNANT BRAIN TUMOR
$297,986Daniel Scott Marcus · Washington University · R01 · FY2013 · NS
Improving Delivery of Molecularly-Targeted Therapy to Invasive Glioma Cells
$297,944William F Elmquist · University Of Minnesota · R01 · FY2014 · CA
PRECLINICAL MODELS FOR HUMAN ASTROCYTOMAS
$297,900Washington University · R01 · FY2002 · NS
PRECLINICAL MODELS FOR HUMAN ASTROCYTOMAS
$297,900Washington University · R01 · FY2004 · NS
PRECLINICAL MODELS FOR HUMAN ASTROCYTOMAS
$297,900Washington University · R01 · FY2003 · NS
Mechanisms of Metabolic Gene Mutations in Cancer
$297,887Yue Xiong · Univ Of North Carolina Chapel Hill · R01 · FY2014 · CA
Glioblastoma tumor microenvironmental influence on acquired and inherent cancer therapy resistance.
$297,715Christopher D Willey · University Of Alabama At Birmingham · U01 · FY2020 · CA
TOPIC 382 - INTEGRATED IMAGING AND MOLECULAR ANALYSIS OF GLIOBLASTOMA USING SCOPE SEQ ON THE AIR FLOW
$297,629Steven Gebhart · Cell Microsystems, Inc. · N43 · FY2019 · CA
Project 2: Combined personal neoantigen-targeting cancer vaccines with immune checkpoint blockade for ovarian cancer
$297,580Panagiotis Konstantinopoulos · Dana-Farber Cancer Inst · P50 · FY2023 · CA
Elucidate and Modulate TGF-b Signaling in NK Cells for Glioma Treatment
$297,451Jianhua Yu · Ohio State University · R01 · FY2013 · CA
Influence of DNA repair on PARP Inhibitor efficacy In GBM
$297,244Jann N Sarkaria · Mayo Clinic Rochester · P50 · FY2015 · CA
High-Grade Astrocytoma-Specific Molecular Targeting
$297,189Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2016 · CA
High-Grade Astrocytoma-Specific Molecular Targeting
$297,157Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2018 · CA
High-Grade Astrocytoma-Specific Molecular Targeting
$297,089Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2017 · CA
P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance
$297,042Francis Ali-Osman · Duke University · R01 · FY2013 · CA
The role of HEF1 protein in division and invasion of metastatic breast cancer
$297,040Elena Nikolaevna Pugacheva · West Virginia University · R01 · FY2010 · CA
Using Common Fund data to inform rare disease preclinical models and prioritize drug repurposing
$297,000Brittany Nicole Lasseigne · University Of Alabama At Birmingham · R03 · FY2020 · OD
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor
$297,000Rory A. Fisher · University Of Iowa · R01 · FY2010 · GM
Heat Shock Protein Vaccine Dev: Glioma immunoresistance and PI(3)K/Akt/mTOR pathw
$296,969Andrew T Parsa · University Of California, San Francisco · P50 · FY2007 · CA
High Throughput Screening for SCAP Inhibitors as Pancreas Cancer Therapeutics
$296,913Peter John Espenshade · Johns Hopkins University · R01 · FY2023 · CA